about
Transarterial chemoembolization combined with recombinant human adenovirus type 5 H101 prolongs overall survival of patients with intermediate to advanced hepatocellular carcinoma: a prognostic nomogram study.Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101Increased Overall Survival and Decreased Cancer-Specific Mortality in Patients with Hepatocellular Carcinoma Treated by Transarterial Chemoembolization and Human Adenovirus Type-5 Combination Therapy: a Competing Risk Analysis.The Predictive Value of Staging Systems and Inflammation Scores for Patients with Combined Hepatocellular Cholangiocarcinoma After Surgical Resection: a Retrospective Study.Neutrophil-to-lymphocyte ratio predicts overall survival of patients with combined hepatocellular cholangiocarcinoma.Surgical management of periampullary adenocarcinoma: defining an optimal prognostic lymph node stratification schema.Nomograms predict long-term survival for patients with periampullary adenocarcinoma after pancreatoduodenectomy.A Refined Staging Model for Resectable Pancreatic Ductal Adenocarcinoma Incorporating Examined Lymph Nodes, Location of Tumor and Positive Lymph Nodes RatioOverall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysisPreoperative CEA levels are supplementary to CA19-9 levels in predicting prognosis in patients with resectable intrahepatic cholangiocarcinomaDevelopment and validation of a nomogram to predict liver metastasis in patients with pancreatic ductal adenocarcinoma: a large cohort studyIrreversible electroporation versus radiotherapy after induction chemotherapy on survival in patients with locally advanced pancreatic cancer: a propensity score analysisCompeting risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgeryThe prognostic and predictive value of the combination of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in patients with hepatocellular carcinoma who receive transarterial chemoembolization therapyThe impact of surgery in metastatic pancreatic neuroendocrine tumors: a competing risk analysisImmunomodulatory Effect after Irreversible Electroporation in Patients with Locally Advanced Pancreatic Cancer.Nomogram to Predict Cancer-Specific Survival in Patients with Pancreatic Acinar Cell Carcinoma: A Competing Risk AnalysisEffect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysisA feasible CT feature to differentiate focal-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma
P50
Q33919629-AFCBF2F2-E084-47F0-817E-425DBD5465F5Q36327007-9385DB36-5B94-43F8-9FDE-991BD022C69DQ50050604-2ABC309B-96A7-4ADC-A0E3-26F2EE4FAF57Q52581523-A376C3B5-1D0B-4661-A9E9-A821C3513C0FQ52655169-2188BAF9-4117-425D-8AE8-DD720ED8EF1CQ55385016-0451BF5A-B4E5-47FD-9F14-EB4652C6DCA0Q55414450-16B94192-5AF7-40BA-A8AA-F6672ACF862EQ57493796-31E757A2-687E-4EA7-8DC6-30F87A5097E2Q58798343-9975B7E2-4C78-421A-9192-32FF0DEB1B29Q58798344-05D07892-2ABF-4E06-B6C4-5153B78C44DCQ64070346-91409C96-5D12-419E-B28D-E351C0029BE9Q64083421-3F8DCCC1-D020-450F-9A96-039259E8FD25Q64093805-B847675E-73AF-4945-B5CF-4648E841BF3FQ64228043-6A2565A7-BFE8-4900-95BD-325F11B747AFQ64230390-369B5CAB-ECCB-41EB-BC1A-3AC9AC7C5792Q65002600-D8AAAAAF-B9EA-45CC-B1F2-499DA0DDDD71Q90290572-87FF05CB-FD6F-4AAD-BC98-CF63CE05F224Q92378876-7A735F75-FF31-49DA-9834-B465318B7328Q93008330-C730645D-1353-4A27-9819-3F0A28BB0C34
P50
description
researcher (ORCID 0000-0002-8149-1264)
@en
name
Chaobin He
@en
type
label
Chaobin He
@en
prefLabel
Chaobin He
@en
P31
P496
0000-0002-8149-1264